Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

Bullboard Posts

Comment by Jimpro63on Mar 28, 2020 12:04am

161 Views

Post# 30855339

RE:Today's News a major step forward in the CoronaVirus battle

It's already been happening behing the scenes , or haven't you been following the News . Vaxil Bio is one of the leaders here and a very real , serious Biotechnology Company. Cut the kiddie show between multiple accounts talking to each other lol

Jimpro63 wrote:

Not printing a 3D visor or toilet paper here ; this Company is working overtime and diligently ( in a way that shows care and conscientiousness in one's work or duties ) to develop a Vaccine. Filed more Patent applications and with the other Bio Research patents accomplished previously ,it is a very intriguing/promising Stock to be an owner of currently. Based on the potential of their past and future accomplishments in the Cancer / Tuberculosis research arena, this Company is the "real deal " and recognized/ acknowledged by the World Health Organization for their professionalism in the Biotechnology field.